Search

everythinglearnresearchcommunity

for

Search:↓

High BMI worsens hair growth in women with PCOS.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Overweight women with PCOS are more likely to have excess male hormones.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Most women with hirsutism have mild symptoms and often experience acne, menstrual irregularities, and obesity.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Spironolactone plus finasteride works better for treating hirsutism.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Finasteride and metformin both help treat PCOS, but using them together works best.